Provided By PR Newswire
Last update: Nov 16, 2023
RA'ANANA, Israel, Nov. 16, 2023 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira"), a pioneer in acute respiratory care, today announced its financial results for the third quarter ended September 30, 2023. This quarter, Inspira continued to progress in the development of its novel technology for oxygenating blood, an alternative to traditional mechanical ventilation for respiratory patients. This patented technology, recently bolstered by a grant from the Israeli Innovation Authority and new U.S. patents, is at the heart of Inspira's strategy.
Read more at prnewswire.comNASDAQ:IINNW (11/20/2025, 8:00:01 PM)
0.3099
+0 (+1.44%)
0.915
0 (-0.41%)
Find more stocks in the Stock Screener


